The Lancet Infectious Diseases 今日热榜

The Lancet Infectious Diseases

The Lancet Infectious Diseases The Lancet Infectious Diseases

1.	[Clinical Picture] First report of deep cutaneous fungal infection caused by Nigrograna hydei	Shu-Fen Wang, Jia-Yi Liu, Fang-Fang Bao, Yong-Xia Liu, Chang-Ping Yu, Mei Wu, Fu-Ren Zhang	
2.	[Editorial] doxyPEP: a controversial new tool against STIs	The Lancet Infectious Diseases	
3.	[Newsdesk] HIV stigma in health-care settings in Europe and central Asia	Sanjeet Bagcchi	
4.	[Newsdesk] Global update on hypervirulent Klebsiella pneumoniae	Manjulika Das	
5.	[Newsdesk] Research in brief	Priya Venkatesan	
6.	[Obituary] Tengiz Tsertsvadze	Sanjeet Bagcchi	
7.	[Profile] Farah Qamar—tackling paediatric infectious diseases	Tony Kirby	
8.	[Newsdesk] Global upsurge in dengue in 2024	Priya Venkatesan	
9.	[Newsdesk] Infectious diseases surveillance update	Tanzina Islam	
10.	[Newsdesk] Polio vaccination campaign in Gaza	Talha Burki	
11.	[Newsdesk] Mpox emergency in Africa	Esther Nakkazi	
12.	[Media Watch] Facing COVID-19 in South Africa	Jonathan Blott	
13.	[Media Watch] Biopolitical precarity for women with HIV in South Africa	Emma Starbuck	
14.	[Media Watch] Antiblackness in the Ebola response in Sierra Leone	Elizabeth Haslam	
15.	[Corrections] Correction to Lancet Infect Dis 2024; published online Aug 12. https://doi.org/10.1016/S1473-3099(24)00357-8		
16.	[Correspondence] Community-based mpox and sexually transmitted disease surveillance using discarded condoms in the global south	Dhammika Leshan Wannigama, Mohan Amarasiri, Phatthranit Phattharapornjaroen, Cameron Hurst, Charin Modchang, John Jefferson V Besa, Kazuhiko Miyanaga, Longzhu Cui, Stefan Fernandez, Angkana T Huang, Puey Ounjai, Pathogen Hunters Research Team, Andrew C Singer, Naveen Kumar Devanga Ragupathi, Takashi Furukawa, Kazunari Sei, Asuka Nanbo, Asada Leelahavanichkul, Talerngsak Kanjanabuch, Tanittha Chatsuwan, Paul G Higgins, Daisuke Sano, Anthony Kicic, Jürgen Kurt Rockstroh, Richard Siow, Sam Trowsdale, Parichart Hongsing, Aisha Khatib, Kenji Shibuya, Shuichi Abe	
17.	[Comment] Re-evaluating polio vaccination strategies in Nepal: transitioning from OPV to fIPV for sustained immunity	Bhuvan Saud, Saroj Adhikari	
18.	[Correspondence] Studies of post-exposure prophylaxis with doxycycline should consider population-level selection for antimicrobial resistance	Thibaut Vanbaelen, Sheeba Santhini Manoharan-Basil, Chris Kenyon	
19.	[Correspondence] The global alarm bell is ringing due to the threat of potential severe cases and deaths caused by clade I of monkeypox virus	Min Du, Min Liu, Ben Niu, Jue Liu	
20.	[Media Watch] Tuberculosis in the USA in 1935	Sanjeet Bagcchi	
21.	[Correspondence] Virological characteristics of the SARS-CoV-2 KP.3.1.1 variant	Yu Kaku, Keiya Uriu, Kaho Okumura, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Jumpei Ito, Kei Sato	
22.	[Media Watch] Understanding outbreak preparedness	Manjulika Das	
23.	[Correspondence] Gonorrhoea and chlamydia screening for asymptomatic people with HIV and HIV PrEP users: open issues	Angelo Roberto Raccagni, Antonella Castagna, Silvia Nozza	
24.	[Correspondence] Enhancing wastewater testing for H5N1 surveillance	Ranu S Dhillon, Abraar Karan, Devabhaktuni Srikrishna	
25.	[Correspondence] First diagnoses of Oropouche virus in Europe: how can we strengthen communication and preparedness globally?	Concetta Castilletti, Antonio Mori, Elena Pomari, Andrea Matucci, Giulia Martelli, Salvatore Curiale, Andrea Angheben, Federico Giovanni Gobbi	
26.	[Correspondence] Tracking the spread of avian influenza A(H5N1) with alternative surveillance methods: the example of wastewater data	Francesco Branda, Massimo Ciccozzi, Fabio Scarpa	
27.	[Corrections] Correction to Lancet Infect Dis 2024; 24: e484		
28.	[Media Watch] Living with our distant relatives	Claire Lenahan	
29.	[Comment] Bolstering influenza protection for older adults	Suryaprakash Sambhara, Paul R Knight	
30.	[Articles] Safety and immunogenicity of the intranasal H3N2 M2-deficient single-replication influenza vaccine alone or coadministered with an inactivated influenza vaccine (Fluzone High-Dose Quadrivalent) in adults aged 65–85 years in the USA: a multicentre, randomised, double-blind, double-dummy, phase 1b trial	Joseph Eiden, Carlos Fierro, Alexander White, Matthew Davis, Margaret Rhee, Mark Turner, Bryan Murray, Renee Herber, Roger Aitchison, David Marshall, Michael J Moser, Robert Belshe, Harry Greenberg, Kathleen Coelingh, Yoshihiro Kawaoka, Gabriele Neumann, Pamuk Bilsel	
31.	[Articles] Safety, tolerability, and immunogenicity of an adult pneumococcal conjugate vaccine, V116 (STRIDE-3): a randomised, double-blind, active comparator controlled, international phase 3 trial	Heather L Platt, Christopher Bruno, Erik Buntinx, Enrique Pelayo, Diego Garcia-Huidobro, Elizabeth A Barranco-Santana, Folke Sjoberg, Joon Young Song, Carlos G Grijalva, Walter A Orenstein, Leslie Morgan, Doreen Fernsler, Weifeng Xu, Muhammad Waleed, Jianing Li, Ulrike K Buchwald, STRIDE-3 Study Group	
32.	[Comment] Adult pneumococcal vaccination: what are the gaps?	Claire von Mollendorf, Paul V Licciardi	
33.	[Articles] Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial	Sarah E Silk, Wilmina F Kalinga, Jo Salkeld, Ivanny M Mtaka, Saumu Ahmed, Florence Milando, Ababacar Diouf, Caroline K Bundi, Neema Balige, Omar Hassan, Catherine G Mkindi, Stella Rwezaula, Thabit Athumani, Sarah Mswata, Nasoro S Lilolime, Beatus Simon, Hania Msami, Mohamed Mohamed, Damiano M David, Latipha Mohammed, Gloria Nyaulingo, Bakari Mwalimu, Omary Juma, Tunu G Mwamlima, Ibrahim A Sasamalo, Rose P Mkumbange, Janeth J Kamage, Jordan R Barrett, Lloyd D W King, Mimi M Hou, David Pulido, Cecilia Carnrot, Alison M Lawrie, Rachel E Cowan, Fay L Nugent, Rachel Roberts, Jee-Sun Cho, Carole A Long, Carolyn M Nielsen, Kazutoyo Miura, Simon J Draper, Ally I Olotu, Angela M Minassian	
34.	[Articles] Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort study	Oleksandr Korotych, Jay Achar, Elmira Gurbanova, Arax Hovhannesyan, Nino Lomtadze, Ana Ciobanu, Alena Skrahina, Gunta Dravniece, Liga Kuksa, Michael Rich, Naira Khachatryan, Myroslava Germanovych, Abdullat Kadyrov, Iana Terleieva, Irada Akhundova, Malik Adenov, Myahri Durdyeva, Nana Kiria, Nargiza Parpieva, Natalia Yatskevich, Rovshen Jumayev, Rustam Nurov, Saulius Diktanas, Valentina Vilc, Giovanni Battista Migliori, Askar Yedilbayev	
35.	[Comment] Longevity of modified standard short treatment regimens for rifampicin-resistant tuberculosis	Tom Decroo, Anita Mesic, Ine Decuyper	
36.	[Comment] Getting closer to an effective multi-stage malaria vaccine	Carlota Dobaño, Gemma Moncunill, Quique Bassat	
37.	[Articles] Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-inferiority trial	Cissy Kityo, Ivan K Mambule, Joseph Musaazi, Simiso Sokhela, Henry Mugerwa, Gilbert Ategeka, Fiona Cresswell, Abraham Siika, Josphat Kosgei, Reena Shah, Logashvari Naidoo, Kimton Opiyo, Caroline Otike, Karlien Möller, Arvind Kaimal, Charity Wambui, Veerle Van Eygen, Perry Mohammed, Fafa Addo Boateng, Nicholas I Paton, CARES trial team	
38.	[Comment] Implementing long-acting injectable cabotegravir and rilpivirine in Africa	Chloe Orkin, Kyle Ring	
39.	[Comment] Doxycycline for STIs in men who have sex with men: the next steps	Troy Grennan, Ann N Burchell	
40.	[Articles] Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design	Jean-Michel Molina, Beatrice Bercot, Lambert Assoumou, Emma Rubenstein, Michele Algarte-Genin, Gilles Pialoux, Christine Katlama, Laure Surgers, Cécile Bébéar, Nicolas Dupin, Moussa Ouattara, Laurence Slama, Juliette Pavie, Claudine Duvivier, Benedicte Loze, Lauriane Goldwirt, Severine Gibowski, Manon Ollivier, Jade Ghosn, Dominique Costagliola, ANRS 174 DOXYVAC Study Group	
41.	[Articles] Targeted next-generation sequencing to diagnose drug-resistant tuberculosis: a systematic review and meta-analysis	Tiana Carina Schwab, Lisa Perrig, Pauline Carlotta Göller, Freddy Fernando Guebely De la Hoz, Adrien Philippe Lahousse, Beatrice Minder, Gunar Günther, Orestis Efthimiou, Shaheed Vally Omar, Matthias Egger, Lukas Fenner	
42.	[Comment] Time to change to next-generation sequencing for management of drug-resistant tuberculosis?	Annelies Van Rie, Rob Warren	
43.	[Personal View] Evaluation of a single-dose HPV vaccine strategy for promoting vaccine, health, and gender equity	Mathew Mercuri, Kristy Hackett, Ruanne V Barnabas, Claudia I Emerson	
44.	[Personal View] Urgent considerations for booster vaccination strategies against Ebola virus disease	Wim Adriaensen, Selien Oostvogels, Yves Levy, Bailah Leigh, Hugo Kavunga-Membo, Deborah Watson-Jones	
45.	[Comment] Oral antivirals for acute symptoms and post-acute sequelae in SARS-CoV-2 infection	Vicente Soriano, Víctor Moreno-Torres	
46.	[Articles] Association of nirmatrelvir–ritonavir with post-acute sequelae and mortality in patients admitted to hospital with COVID-19: a retrospective cohort study	Huwen Wang, Yuchen Wei, Chi Tim Hung, Guozhang Lin, Xiaoting Jiang, Conglu Li, Katherine Min Jia, Carrie Ho Kwan Yam, Tsz Yu Chow, Janice Ying-en Ho, Yawen Wang, Shi Zhao, Zihao Guo, Kehang Li, Aimin Yang, Chris Ka Pun Mok, David S C Hui, Eng Kiong Yeoh, Ka Chun Chong	
47.	[Historical Review] Social histories of public health misinformation and infodemics: case studies of four pandemics	Sabrina L Jin, Jessica Kolis, Jessica Parker, Dylan A Proctor, Dimitri Prybylski, Claire Wardle, Neetu Abad, Kathryn A Brookmeyer, Christopher Voegeli, Howard Chiou	
48.	[Review] Consensus definitions in imported human schistosomiasis: a GeoSentinel and TropNet Delphi study	Francesca Tamarozzi, Cristina Mazzi, Spinello Antinori, Marta Arsuaga, Sören L Becker, Emmanuel Bottieau, Daniel Camprubi-Ferrer, Eric Caumes, Alexandre Duvignaud, Martin P Grobusch, Stephane Jaureguiberry, Sabine Jordan, Andreas Mueller, Andreas Neumayr, Jose A Perez-Molina, Joaquin Salas-Coronas, Fernando Salvador, Lina R Tomasoni, Jaap J van Hellemond, Stephen D Vaughan, Linda J Wammes, Lorenzo Zammarchi, Dora Buonfrate, Ralph Huits, Lisette van Lieshout, Federico Gobbi	

更新于 58 分钟前

近期历史最近 100 条记录

2024-09-26	[Clinical Picture] First report of deep cutaneous fungal infection caused by Nigrograna hydei	Shu-Fen Wang, Jia-Yi Liu, Fang-Fang Bao, Yong-Xia Liu, Chang-Ping Yu, Mei Wu, Fu-Ren Zhang	
2024-09-26	[Editorial] doxyPEP: a controversial new tool against STIs	The Lancet Infectious Diseases	
2024-09-26	[Newsdesk] HIV stigma in health-care settings in Europe and central Asia	Sanjeet Bagcchi	
2024-09-26	[Newsdesk] Global update on hypervirulent Klebsiella pneumoniae	Manjulika Das	
2024-09-26	[Newsdesk] Research in brief	Priya Venkatesan	
2024-09-26	[Obituary] Tengiz Tsertsvadze	Sanjeet Bagcchi	
2024-09-26	[Profile] Farah Qamar—tackling paediatric infectious diseases	Tony Kirby	
2024-09-26	[Newsdesk] Global upsurge in dengue in 2024	Priya Venkatesan	
2024-09-26	[Newsdesk] Infectious diseases surveillance update	Tanzina Islam	
2024-09-26	[Newsdesk] Polio vaccination campaign in Gaza	Talha Burki	
2024-09-26	[Newsdesk] Mpox emergency in Africa	Esther Nakkazi	
2024-09-26	[Media Watch] Facing COVID-19 in South Africa	Jonathan Blott	
2024-09-26	[Media Watch] Biopolitical precarity for women with HIV in South Africa	Emma Starbuck	
2024-09-26	[Media Watch] Antiblackness in the Ebola response in Sierra Leone	Elizabeth Haslam	
2024-09-26	[Corrections] Correction to Lancet Infect Dis 2024; published online Aug 12. https://doi.org/10.1016/S1473-3099(24)00357-8		
2024-09-26	[Correspondence] Community-based mpox and sexually transmitted disease surveillance using discarded condoms in the global south	Dhammika Leshan Wannigama, Mohan Amarasiri, Phatthranit Phattharapornjaroen, Cameron Hurst, Charin Modchang, John Jefferson V Besa, Kazuhiko Miyanaga, Longzhu Cui, Stefan Fernandez, Angkana T Huang, Puey Ounjai, Pathogen Hunters Research Team, Andrew C Si	
2024-09-26	[Correspondence] Studies of post-exposure prophylaxis with doxycycline should consider population-level selection for antimicrobial resistance	Thibaut Vanbaelen, Sheeba Santhini Manoharan-Basil, Chris Kenyon	
2024-09-26	[Comment] Re-evaluating polio vaccination strategies in Nepal: transitioning from OPV to fIPV for sustained immunity	Bhuvan Saud, Saroj Adhikari	
2024-09-26	[Correspondence] The global alarm bell is ringing due to the threat of potential severe cases and deaths caused by clade I of monkeypox virus	Min Du, Min Liu, Ben Niu, Jue Liu	
2024-09-26	[Correspondence] Virological characteristics of the SARS-CoV-2 KP.3.1.1 variant	Yu Kaku, Keiya Uriu, Kaho Okumura, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Jumpei Ito, Kei Sato	
2024-09-26	[Media Watch] Tuberculosis in the USA in 1935	Sanjeet Bagcchi	
2024-09-26	[Media Watch] Understanding outbreak preparedness	Manjulika Das	
2024-09-26	[Correspondence] Enhancing wastewater testing for H5N1 surveillance	Ranu S Dhillon, Abraar Karan, Devabhaktuni Srikrishna	
2024-09-26	[Correspondence] Gonorrhoea and chlamydia screening for asymptomatic people with HIV and HIV PrEP users: open issues	Angelo Roberto Raccagni, Antonella Castagna, Silvia Nozza	
2024-09-26	[Correspondence] First diagnoses of Oropouche virus in Europe: how can we strengthen communication and preparedness globally?	Concetta Castilletti, Antonio Mori, Elena Pomari, Andrea Matucci, Giulia Martelli, Salvatore Curiale, Andrea Angheben, Federico Giovanni Gobbi	
2024-09-26	[Correspondence] Tracking the spread of avian influenza A(H5N1) with alternative surveillance methods: the example of wastewater data	Francesco Branda, Massimo Ciccozzi, Fabio Scarpa	
2024-09-26	[Corrections] Correction to Lancet Infect Dis 2024; 24: e484		
2024-09-26	[Media Watch] Living with our distant relatives	Claire Lenahan	
2024-09-26	[Articles] Safety and immunogenicity of the intranasal H3N2 M2-deficient single-replication influenza vaccine alone or coadministered with an inactivated influenza vaccine (Fluzone High-Dose Quadrivalent) in adults aged 65–85 years in the USA: a multicent	Joseph Eiden, Carlos Fierro, Alexander White, Matthew Davis, Margaret Rhee, Mark Turner, Bryan Murray, Renee Herber, Roger Aitchison, David Marshall, Michael J Moser, Robert Belshe, Harry Greenberg, Kathleen Coelingh, Yoshihiro Kawaoka, Gabriele Neumann,	
2024-09-26	[Comment] Bolstering influenza protection for older adults	Suryaprakash Sambhara, Paul R Knight	
2024-09-26	[Articles] Safety, tolerability, and immunogenicity of an adult pneumococcal conjugate vaccine, V116 (STRIDE-3): a randomised, double-blind, active comparator controlled, international phase 3 trial	Heather L Platt, Christopher Bruno, Erik Buntinx, Enrique Pelayo, Diego Garcia-Huidobro, Elizabeth A Barranco-Santana, Folke Sjoberg, Joon Young Song, Carlos G Grijalva, Walter A Orenstein, Leslie Morgan, Doreen Fernsler, Weifeng Xu, Muhammad Waleed, Jian	
2024-09-26	[Comment] Adult pneumococcal vaccination: what are the gaps?	Claire von Mollendorf, Paul V Licciardi	
2024-09-26	[Articles] Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial	Sarah E Silk, Wilmina F Kalinga, Jo Salkeld, Ivanny M Mtaka, Saumu Ahmed, Florence Milando, Ababacar Diouf, Caroline K Bundi, Neema Balige, Omar Hassan, Catherine G Mkindi, Stella Rwezaula, Thabit Athumani, Sarah Mswata, Nasoro S Lilolime, Beatus Simon, H	
2024-09-26	[Articles] Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort study	Oleksandr Korotych, Jay Achar, Elmira Gurbanova, Arax Hovhannesyan, Nino Lomtadze, Ana Ciobanu, Alena Skrahina, Gunta Dravniece, Liga Kuksa, Michael Rich, Naira Khachatryan, Myroslava Germanovych, Abdullat Kadyrov, Iana Terleieva, Irada Akhundova, Malik A	
2024-09-26	[Comment] Longevity of modified standard short treatment regimens for rifampicin-resistant tuberculosis	Tom Decroo, Anita Mesic, Ine Decuyper	
2024-09-26	[Comment] Getting closer to an effective multi-stage malaria vaccine	Carlota Dobaño, Gemma Moncunill, Quique Bassat	
2024-09-26	[Articles] Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-inferiority trial	Cissy Kityo, Ivan K Mambule, Joseph Musaazi, Simiso Sokhela, Henry Mugerwa, Gilbert Ategeka, Fiona Cresswell, Abraham Siika, Josphat Kosgei, Reena Shah, Logashvari Naidoo, Kimton Opiyo, Caroline Otike, Karlien Möller, Arvind Kaimal, Charity Wambui, Veerle	
2024-09-26	[Comment] Implementing long-acting injectable cabotegravir and rilpivirine in Africa	Chloe Orkin, Kyle Ring	
2024-09-26	[Articles] Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design	Jean-Michel Molina, Beatrice Bercot, Lambert Assoumou, Emma Rubenstein, Michele Algarte-Genin, Gilles Pialoux, Christine Katlama, Laure Surgers, Cécile Bébéar, Nicolas Dupin, Moussa Ouattara, Laurence Slama, Juliette Pavie, Claudine Duvivier, Benedicte Lo	
2024-09-26	[Comment] Doxycycline for STIs in men who have sex with men: the next steps	Troy Grennan, Ann N Burchell	
2024-09-26	[Articles] Targeted next-generation sequencing to diagnose drug-resistant tuberculosis: a systematic review and meta-analysis	Tiana Carina Schwab, Lisa Perrig, Pauline Carlotta Göller, Freddy Fernando Guebely De la Hoz, Adrien Philippe Lahousse, Beatrice Minder, Gunar Günther, Orestis Efthimiou, Shaheed Vally Omar, Matthias Egger, Lukas Fenner	
2024-09-26	[Comment] Time to change to next-generation sequencing for management of drug-resistant tuberculosis?	Annelies Van Rie, Rob Warren	
2024-09-26	[Personal View] Urgent considerations for booster vaccination strategies against Ebola virus disease	Wim Adriaensen, Selien Oostvogels, Yves Levy, Bailah Leigh, Hugo Kavunga-Membo, Deborah Watson-Jones	
2024-09-26	[Personal View] Evaluation of a single-dose HPV vaccine strategy for promoting vaccine, health, and gender equity	Mathew Mercuri, Kristy Hackett, Ruanne V Barnabas, Claudia I Emerson	
2024-09-26	[Articles] Association of nirmatrelvir–ritonavir with post-acute sequelae and mortality in patients admitted to hospital with COVID-19: a retrospective cohort study	Huwen Wang, Yuchen Wei, Chi Tim Hung, Guozhang Lin, Xiaoting Jiang, Conglu Li, Katherine Min Jia, Carrie Ho Kwan Yam, Tsz Yu Chow, Janice Ying-en Ho, Yawen Wang, Shi Zhao, Zihao Guo, Kehang Li, Aimin Yang, Chris Ka Pun Mok, David S C Hui, Eng Kiong Yeoh,	
2024-09-26	[Comment] Oral antivirals for acute symptoms and post-acute sequelae in SARS-CoV-2 infection	Vicente Soriano, Víctor Moreno-Torres	
2024-09-26	[Historical Review] Social histories of public health misinformation and infodemics: case studies of four pandemics	Sabrina L Jin, Jessica Kolis, Jessica Parker, Dylan A Proctor, Dimitri Prybylski, Claire Wardle, Neetu Abad, Kathryn A Brookmeyer, Christopher Voegeli, Howard Chiou	
2024-09-26	[Review] Consensus definitions in imported human schistosomiasis: a GeoSentinel and TropNet Delphi study	Francesca Tamarozzi, Cristina Mazzi, Spinello Antinori, Marta Arsuaga, Sören L Becker, Emmanuel Bottieau, Daniel Camprubi-Ferrer, Eric Caumes, Alexandre Duvignaud, Martin P Grobusch, Stephane Jaureguiberry, Sabine Jordan, Andreas Mueller, Andreas Neumayr,	
2024-08-22	[Newsdesk] Global Sanitation Summit 2024	Manjulika Das	
2024-08-22	[Clinical Picture] Strongyloides stercoralis hyperinfection syndrome	Lemna Jacob, Ayan Basu, Dipankar Paul, Yogiraj Ray, Nazneen Nahar Begam, Christy Varghese John	
2024-08-22	[Newsdesk] Chad eliminates gambiense sleeping sickness	Alix Boisson-Walsh	
2024-08-22	[Comment] Waiting is no longer an option for household contacts of people with drug-resistant tuberculosis	Jean Pannikottu, Anja Reuter, Elize Pietersen, Goodman Makhanda, Johnny Daniels, Busisiwe Beko, Ivy Apolisi, Jennifer Furin	
2024-08-22	[Newsdesk] Setbacks and advances in the global HIV response	Ed Holt	
2024-08-22	[Newsdesk] Infectious disease surveillance update	Aimee Ramgolam	
2024-08-22	[Newsdesk] First report from the UK COVID-19 Inquiry	Talha Burki	
2024-08-22	[Newsdesk] Research in brief	Priya Venkatesan	
2024-08-22	[Obituary] Phyllis Dako-Gyeke	Sanjeet Bagcchi	
2024-08-22	[Profile] Amanda Kvalsvig—from paediatrics to epidemiology	Tony Kirby	
2024-08-22	[Newsdesk] Brazil to distribute paediatric antimalarial in Amazon	Sanjeet Bagcchi	
2024-08-22	[Newsdesk] Limited progress towards immunisation targets in 2023	Timothy Jesudason	
2024-08-22	[Editorial] Oropouche fever, the mysterious threat	The Lancet Infectious Diseases	
2024-08-22	[Correspondence] Emergence of an extensively drug-resistant Neisseria gonorrhoeae clone	Sebastiaan J van Hal, Norelle Sherry, Geoff Coombs, Shakeel Mowlaboccus, David M Whiley, Monica M Lahra	
2024-08-22	[Media Watch] Anthony Fauci: a life on page	Bipin Adhikari, Lorenz Von Seidlein	
2024-08-22	[Correspondence] Mortality of H5N1 human infections might be due to H5N1 virus pneumonia and could decrease by switching receptor	Guido Granata, Lone Simonsen, Nicola Petrosillo, Eskild Petersen	
2024-08-22	[Correspondence] Recombination as an evolutionary driver of MERS-related coronavirus emergence	Jarel Elgin Tolentino, Spyros Lytras, Jumpei Ito, Edward C Holmes, Kei Sato	
2024-08-22	[Correspondence] Alarming Plasmodium falciparum resistance to artemisinin-based combination therapy in Africa: the critical role of the partner drug	Anders Björkman, Pedro Gil, Michael Alifrangis	
2024-08-22	[Correspondence] Artificial intelligence to transform public health in Africa	Collins Kipngetich Tanui, Nicaise Ndembi, Yenew Kebede, Sofonias Kifle Tessema	
2024-08-22	[Correspondence] The potential role of the 4CMenB vaccine in combating gonorrhoea: the need for nuance in interpreting the DOXYVAC trial	Peter J White, Trystan Leng, Dariya Nikitin, Lilith K Whittles	
2024-08-22	[Corrections] Correction to Lancet Infect Dis 2024; published online May 31. https://doi.org/10.1016/S1473-3099(24)00221-4		
2024-08-22	[Corrections] Correction to Lancet Infect Dis 2022; 22: 265–73		
2024-08-22	[Corrections] Correction to Lancet Infect Dis 2024; published online May 31. https://doi.org/10.1016/S1473-3099(24)00221-4		
2024-08-22	[Articles] Optimisation of dose level and vaccination schedule for the VLA15 Lyme borreliosis vaccine candidate among healthy adults: two randomised, observer-blind, placebo-controlled, multicentre, phase 2 studies	Nicole Bézay, Laura Wagner, Vera Kadlecek, Michaela Obersriebnig, Nina Wressnigg, Romana Hochreiter, Martina Schneider, Katrin Dubischar, Ulla Derhaschnig, Anton Klingler, Julian Larcher-Senn, Susanne Eder-Lingelbach, Wolfgang Bender	
2024-08-22	[Comment] Vaccination hesistancy in Lyme borreliosis	Raymond J Dattwyler, Paul M Arnaboldi	
2024-08-22	[Articles] Long-term efficacy and immunogenicity of Ad26.RSV.preF–RSV preF protein vaccine (CYPRESS): a randomised, double-blind, placebo-controlled, phase 2b study	Ann R Falsey, Tessa Hosman, Arangassery Rosemary Bastian, Sjouke Vandenberghe, Eric K H Chan, Macaya Douoguih, Esther Heijnen, Christy A Comeaux, Benoit Callendret, CYPRESS investigators	
2024-08-22	[Comment] The long-term efficacy of a respiratory syncytial virus vaccine for older adults	Charles J Sande	
2024-08-22	[Articles] Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial	Muge Cevik, Lindsay C Thompson, Caryn Upton, Valéria Cavalcanti Rolla, Mookho Malahleha, Blandina Mmbaga, Nosipho Ngubane, Zamzurina Abu Bakar, Mohammed Rassool, Ebrahim Variava, Rodney Dawson, Suzanne Staples, Umesh Lalloo, Cheryl Louw, Francesca Conradi	
2024-08-22	[Comment] A bedaquiline, pretomanid, moxifloxacin, and pyrazinamide regimen for drug-susceptible and drug-resistant tuberculosis	Guofang Deng, Liang Fu	
2024-08-22	[Articles] Relative vaccine protection, disease severity, and symptoms associated with the SARS-CoV-2 omicron subvariant BA.2.86 and descendant JN.1 in Denmark: a nationwide observational study	Ida Rask Moustsen-Helms, Peter Bager, Tine Graakjær Larsen, Frederik Trier Møller, Lasse Skafte Vestergaard, Morten Rasmussen, Christian Holm Hansen, SSI-DMC Study Group	
2024-08-22	[Comment] Immune evasiveness of SARS-CoV-2 variants and vaccine selection	Malin Inghammar, Fredrik Kahn	
2024-08-22	[Articles] Field evaluation of validity and feasibility of Pan-Lassa rapid diagnostic test for Lassa fever in Abakaliki, Nigeria: a prospective diagnostic accuracy study	Jelte Elsinga, Temmy Sunyoto, Letizia di Stefano, Pier Francesco Giorgetti, Htet Aung Kyi, Chiara Burzio, Ximena Campos Moreno, Chiedozie K Ojide, Nnennaya Ajayi, Richard Ewah, Emeka O Ogah, Chioma Dan-Nwafor, Anthony Ahumibe, Chinwe Lucia Ochu, Adebola O	
2024-08-22	[Comment] Rapid diagnostic tests for Lassa fever: what do we aim for?	Mirjam Groger, Michael Ramharter	
2024-08-22	[Articles] Genotypic analysis of RTS,S/AS01E malaria vaccine efficacy against parasite infection as a function of dosage regimen and baseline malaria infection status in children aged 5–17 months in Ghana and Kenya: a longitudinal phase 2b randomised cont	Michal Juraska, Angela M Early, Li Li, Stephen F Schaffner, Marc Lievens, Akanksha Khorgade, Brian Simpkins, Nima S Hejazi, David Benkeser, Qi Wang, Laina D Mercer, Samuel Adjei, Tsiri Agbenyega, Scott Anderson, Daniel Ansong, Dennis K Bii, Patrick B Y Bu	
2024-08-22	[Comment] Asymptomatic parasitemia and RTS,S vaccine efficacy	Nobuko Arisue, Nirianne Marie Q Palacpac	
2024-08-22	[Articles] Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV)	Phrutsamon Wongnak, William H K Schilling, Podjanee Jittamala, Simon Boyd, Viravarn Luvira, Tanaya Siripoon, Thundon Ngamprasertchai, Elizabeth M Batty, Shivani Singh, Jindarat Kouhathong, Watcharee Pagornrat, Patpannee Khanthagan, Borimas Hanboonkunupaka	
2024-08-22	[Comment] Identifying efficacious SARS-CoV-2 antivirals in a changing immune landscape	Leo G Visser	
2024-08-22	[Articles] Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021	GBD 2021 Lower Respiratory Infections and Antimicrobial Resistance Collaborators	
2024-08-22	[Comment] Unveiling the viral aetiologies of lower respiratory infections	You Li, Xin Wang	
2024-08-22	[Personal View] The emergence of artemisinin partial resistance in Africa: how do we respond?	Philip J Rosenthal, Victor Asua, Jeffrey A Bailey, Melissa D Conrad, Deus S Ishengoma, Moses R Kamya, Charlotte Rasmussen, Fitsum G Tadesse, Aline Uwimana, David A Fidock	
2024-08-22	[Review] The epidemiology, transmission, diagnosis, and management of drug-resistant tuberculosis—lessons from the South African experience	Kogieleum Naidoo, Rubeshan Perumal, Helen Cox, Barun Mathema, Marian Loveday, Nazir Ismail, Shaheed Vally Omar, Sophia B Georghiou, Amrita Daftary, Max O'Donnell, Norbert Ndjeka	
2024-08-22	[Review] Use of a meningococcal group B vaccine (4CMenB) in populations at high risk of gonorrhoea in the UK	Shamez N Ladhani, Peter J White, Helen Campbell, Sema Mandal, Ray Borrow, Nick Andrews, Sunil Bhopal, John Saunders, Hamish Mohammed, Lana Drisdale-Gordon, Emma Callan, Katy Sinka, Kate Folkard, Helen Fifer, Mary E Ramsay	
2024-08-22	[Personal View] Accelerating antibiotic access and stewardship: a new model to safeguard public health	Jennifer Cohn, Marc Mendelson, Souha S Kanj, Nusrat Shafiq, Icaro Boszczowski, Ramanan Laxminarayan	
2024-07-25	[Newsdesk] Gavi, the Vaccine Alliance supports rabies vaccination	Talha Burki	
2024-07-25	[Clinical Picture] A persistent vesiculo-pustular rash, eosinophilia, and itchy parents: think of scabies	Yana Marie Dimech, Eileen Clark, David Pace	
2024-07-25	[Newsdesk] Outbreaks compound Brazil's flooding disaster	Tony Kirby	
2024-07-25	[Newsdesk] Rising measles cases in Europe—a threat to children	Manjulika Das	
2024-07-25	[Obituary] John Sever	Sanjeet Bagcchi	
2024-07-25	[Newsdesk] Research in brief	Priya Venkatesan	
2024-07-25	[Profile] Mallika Imwong—championing malaria genomics	Udani Samarasekera	
2024-07-25	[Profile] Lise Musset— studying antimalarial resistance in America	Farooq Kazi, Ammara Mushtaq	
2024-07-25	[Profile] Naomi Lucchi—from malaria to pandemic preparedness	Tony Kirby	